Baltimore Washington Financial Advisors, Inc. Abb Vie Inc. Transaction History
Baltimore Washington Financial Advisors, Inc.
- $2.18 Billion
- Q3 2025
A detailed history of Baltimore Washington Financial Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Baltimore Washington Financial Advisors, Inc. holds 1,790 shares of ABBV stock, worth $418,860. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,790
Previous 1,730
3.47%
Holding current value
$418,860
Previous $321,000
28.97%
% of portfolio
0.02%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding ABBV
# of Institutions
4,492Shares Held
1.28BCall Options Held
16.9MPut Options Held
15.2M-
Vanguard Group Inc Valley Forge, PA178MShares$41.6 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.8MShares$18.7 Billion0.66% of portfolio
-
Jpmorgan Chase & CO New York, NY56.5MShares$13.2 Billion0.86% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.75 Billion0.61% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $414B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...